Walleye Capital
RCKTW icon

Walleye Capital’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Walleye Capital’s Portfolio RCKTW Stock Details RCKTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.86K Hold
284,345
– – ﹤0.01% 4191
2025
Q4 		$6.91K Sell
284,345
-309,286
-52% -$10.1K ﹤0.01% 4321
2025
Q3 		$23.3K Sell
593,631
-49,216
-8% -$1.92K ﹤0.01% 4188
2025
Q2 		$25.3K Sell
642,847
-23,122
-3% -$962 ﹤0.01% 4200
2025
Q1 		$31.3K Sell
665,969
-5,774
-0.9% -$375 ﹤0.01% 3944
2024
Q4 		$23K Sell
671,743
-49,162
-7% -$2.4K ﹤0.01% 4485
2024
Q3 		$50.5K Hold
720,905
– – ﹤0.01% 4638
2024
Q2 		$43.8K Hold
720,905
– – ﹤0.01% 4967
2024
Q1 		$216K Sell
720,905
-15
-0% -$5 ﹤0.01% 3930
2023
Q4 		$353K Sell
720,920
-39,671
-5% -$11K ﹤0.01% 3233
2023
Q3 		$129K Buy
760,591
+45,557
+6% +$7.18K ﹤0.01% 3811
2023
Q2 		$136K Hold
715,034
– – ﹤0.01% 3303
2023
Q1 		$39.5K Buy
+715,034
New +$138K ﹤0.01% 3257

Other funds holding RCKTW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Capital's RCKTW Position: Q1 2026 in Review

Walleye Capital held its Rocket Pharmaceuticals Warrant (RCKTW) position steady in Q1 2026 at 284,345 shares worth $5.86K. The position accounts for ﹤0.01% of the portfolio, ranked #4191.

Walleye Capital first reported a position in RCKTW in Q1 2023 and has held it in 13 quarters since. The position peaked at $353K in Q4 2023. 10 funds tracked by Wall St. Rank hold RCKTW as of Q1 2026.

  • Walleye Capital held 284,345 shares of Rocket Pharmaceuticals Warrant worth $5.86K as of Q1 2026.
  • Walleye Capital left its Rocket Pharmaceuticals Warrant share count unchanged in Q1 2026.
  • Rocket Pharmaceuticals Warrant made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4191 holding.
  • Walleye Capital first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and has held it in 13 quarters since.
  • Walleye Capital's Rocket Pharmaceuticals Warrant position peaked at $353K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.